Novartis Pavillon and Global Health Research: RemIND Data for Rhapsido® at EAACI
Scientific research and healthcare innovation continue to shape modern medicine, a theme deeply explored at the Novartis Pavillon through its immersive Wonders of Medicine exhibition. Groundbreaking developments in immunology further highlight how ongoing clinical investigations address major medical challenges worldwide. Recent findings presented at the European Academy of Allergy and Clinical Immunology (EAACI) Congress demonstrate significant progress in targeted therapies for chronic conditions.
Clinical Trial Insights and Patient Impact
Data from the global RemIND trial presented at the EAACI Congress show that Rhapsido® (remibrutinib) met its primary endpoints across the three most common subtypes of chronic inducible urticaria (CIndU). As a condition affecting an estimated 29 million people globally, CIndU often leaves many individuals dealing with significant symptom burdens despite traditional treatments like H1-antihistamines. The trial results indicate that Rhapsido demonstrated statistically significant and clinically meaningful symptom control compared to placebo, offering a favorable safety profile.
The three primary CIndU subtypes evaluated in the trial include symptomatic dermographism, cold urticaria, and cholinergic urticaria. By targeting the BTK pathway involved in histamine release, the therapy aims to provide sustained relief where approved targeted options have previously been unavailable. Regulatory submissions, including a supplemental New Drug Application to the U.S. Food and Drug Administration for the symptomatic dermographism subtype, point toward broader global health authority reviews throughout 2026.
Exploring Science and Healthcare in Basel
Visitors interested in the intersection of cutting-edge pharmacology, drug development, and future healthcare solutions can explore these topics further through public installations on the Rhine. To discover more cultural spots, exhibitions, and scientific displays across the city, browse the map view, check out the museums list, or plan your visit with Musemap (musemap.art).
